Functional expression of μ-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon

Digestive Diseases and Sciences

Volumn 53, Issue 2, 2008, Pages 461-466

  Nylund, Gunnar ^a   Pettersson, Ann ^b,c   Bengtsson, Cecilia ^b   Khorram Manesh, Amir ^a   Nordgren, Svante ^b   Delbro, Dick S ^b,c  

^a Department of Anaesthesiology and Intensive Care   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Opioid receptors; Colon cancer; HT 29 human colon cancer cell line; Immunohistochemistry; Morphine; Proliferation; Urokinase type plasminogen activator

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR; UROKINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER LOCALIZATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; CYTOPLASM; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL NUCLEUS; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; DISEASE PROGRESSION; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MORPHINE; NARCOTICS; NEOPLASM INVASIVENESS; RECEPTORS, OPIOID, MU; URINARY PLASMINOGEN ACTIVATOR;

EID: 38649143679     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9897-y     Document Type: Article

References (15)

1. Gutstein HB, Akil H (2001) Opioid analgesics. In: Hartman JG, Limbird LE (eds) The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 569-619
2. Holden JE, Jeong Y, Forrest JM (2005) The endogenous opioid system and clinical pain management. AACN Clin Issues 16:291-301
3. Corbett AD, Henderson G, McKnight AT, Paterson SJ (2006) 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharm 147[Suppl 1]:S153-S162
4. Tegeder I, Grosch S, Schmidtko A, Haussler A, Schmidt H, Niederberger E, Scholich K, Geisslinger G (2003) G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 63:1846-1852
5. Sharp BM (2006) Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immunol 20:9-14
6. Duffy MJ, Duggan C (2004) The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer. Clin Biochem 37:541-548
7. Gillies RJ, Didier N, Denton M (1986) Determination of cell number in monolayer cultures. Anal Biochem 159:109-113
8. Yeager MP, Colacchio TA (1991) Effect of morphine on growth of metastatic colon cancer in vivo. Arch Surg 126:454-456
9. Zagon IS, Hytrik SD, Lang CM, Smith JP, McGarrity TJ, Wu Y, McLaughlin PJ (1996) Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer. Am J Physiol 271:R780-R786
10. Zagon IS, McLaughlin PJ (2003) Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37:79-88
11. Tegeder I, Geisslinger G (2004) Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharm Rev 56:351-369
12. Sacerdote P (2006) Opioids and the immune system. Palliat Med 20[Suppl 1]:s9-15
13. Lang ME, Davison JS, Bates SL, Meddings JB (1996) Opioid receptors on guinea-pig intestinal crypt epithelial cells. J Physiol 497:161-174
14. Neudeck BL, Loeb JM (2002) Endomorphin-1 alters interleukin-8 secretion in Caco-2 cells via a receptor mediated process. Immunol Lett 84:217-221
15. Hytrek SD, Smith JP, McGarrity TJ, McLaughlin PJ, Lang CM, Zagon IS (1996) Identification and characterization of zeta-opioid receptor in human colon cancer. Am J Physiol 271:R115-R121